MedPath

Brain-oscillation Synchronised Stimulation of the Prefrontal Cortex

Not Applicable
Completed
Conditions
Depression
Interventions
Device: Negative-peak-triggered-TMS
Device: Intermittent theta-burst stimulation
Device: Open-loop replay TMS
Registration Number
NCT02920840
Lead Sponsor
University Hospital Tuebingen
Brief Summary

Combining TMS and EEG, this study investigates a personalized therapeutic non-invasive brain stimulation protocol in patients with major depression, whereby the timing of the TMS pulses is synchronized with the instantaneous phase of ongoing brain oscillations in order to modulate the inter-hemispheric left and right dorso-lateral prefrontal cortical brain network.

Detailed Description

Major depressive disorder is a severe psychiatric illness with a lifetime prevalence of about 8-16%. Many patients fail to achieve complete remission of symptoms under antidepressant medication, with about 10% of patients being chronically resistant to several psychopharmacological treatments. Development of alternative non-pharmacological treatments is therefore essential to improve patient care.

Repetitive transcranial magnetic stimulation (rTMS) offers therapeutic potential in this context. Current protocols apply high-frequency rTMS over left dorsolateral prefrontal cortex (DLPFC) to reverse the increased alpha-band oscillatory activity and cortical hypo-excitability in patients with depression. However, translation of rTMS therapy into routine clinical practice has been limited due to low efficacy and high inter-individual variability.

This study aims to optimize rTMS stimulation protocols for MDD by deterministically coupling the timing of TMS to the ongoing oscillatory neural activity in the underlying cortex as measured in real-time with high-density surface EEG. It is hypothesized that alpha phase-locked rTMS of the left DLPFC reverses increased alpha-band oscillatory activity and cortical hypo-excitability more efficiently than current open-loop rTMS protocols used in the treatment of MDD.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
17
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Negative-peak-triggered-TMSNegative-peak-triggered-TMSIntervention: application of 200 brain-state dependent 100 Hz TMS triplet bursts triggered at the negative peak phase of the ongoing endogenous alpha-band oscillation (as detected by surface EEG over left dlPFC)
Intermittent theta-burst stimulationIntermittent theta-burst stimulationIntervention: application of 200 TMS triplet bursts (at 100 Hz, inter-burst interval 200ms) over left dorsolateral prefrontal cortex
Open-loop replay TMSOpen-loop replay TMSIntervention: application of the same sequence of TMS pulses as in condition "Negative-peak-triggered-TMS", i.e. irrespective of ongoing brain state over left dlPFC
Primary Outcome Measures
NameTimeMethod
Change from baseline in cortical excitability 30 minutes after the intervention30 minutes

TMS-evoked EEG potentials from left dlPFC

Secondary Outcome Measures
NameTimeMethod
Change from baseline in EEG alpha power 30 minutes after the intervention30 minutes

Left vs. right dlPFC relative spectral power in 8-12 Hz frequency band

Change from baseline in verbal working memory performance 30 minutes after the intervention30 minutes

Verbal working memory task

Trial Locations

Locations (1)

University Neurology Hospital

🇩🇪

Tuebingen, BW, Germany

© Copyright 2025. All Rights Reserved by MedPath